Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. announced today an update on the ongoing regulatory review of the Marketing Authorization Application for lecanemab as ...
A name echoes through the corridors of Warsaw Citadel, the Polish capital's fortress where EU home affairs ministers are discussing how to crack down on irregular migration: that of Donald Trump. But ...